Nascent Biotech, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of various forms of cancer. It is developing Pritumumab, a monoclonal antibody to treat patients with brain cancer malignancies, such as glioblastoma and malignant astrocytoma, as well as lung and breast cancer metastases to the brain; and pancreatic cancer. The company is based in Vero Beach, Florida.
Industry, Sector and Symbol
Industry Agricultural Commodities/Milling
Sub-IndustryN/A
SectorProcess Industries
CIKN/A
Phone(612) 961-5656
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Nascent Biotech (OTCMKTS:NBIO) Frequently Asked Questions
What is Nascent Biotech's stock symbol?
Nascent Biotech trades on the OTCMKTS under the ticker symbol "NBIO."
Has Nascent Biotech been receiving favorable news coverage?
News stories about NBIO stock have been trending somewhat negative recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Nascent Biotech earned a media sentiment score of -1.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Nascent Biotech.
Who are some of Nascent Biotech's key competitors?
Who are Nascent Biotech's key executives?
Nascent Biotech's management team includes the folowing people:
- Mr. Sean Carrick, Pres, Sec. & Director (Age 51)
- Mr. Lowell Holden, CFO, Chief Accounting Officer & Director (Age 76)
- Dr. Brandon J. Price, Exec. VP of Bus. Devel. & Director (Age 71)
- Mr. Onur Boyman, Co-Founder and Director
- Mr. Jonathan Sprent, Co-Founder and Director
How do I buy shares of Nascent Biotech?
Shares of NBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Nascent Biotech's stock price today?
One share of NBIO stock can currently be purchased for approximately $0.12.
What is Nascent Biotech's official website?
How can I contact Nascent Biotech?
Nascent Biotech's mailing address is 601 21st St Ste 300, VERO BEACH, FL 32960-0860, United States. The company can be reached via phone at (612) 961-5656.
MarketBeat Community Rating for Nascent Biotech (OTCMKTS NBIO)
MarketBeat's community ratings are surveys of what our community members think about Nascent Biotech and other stocks. Vote "Outperform" if you believe NBIO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NBIO will underperform the S&P 500 over the long term. You may vote once every thirty days.
